US Stock MarketDetailed Quotes

NAUT Nautilus Biotechnology

Watchlist
  • 2.240
  • -0.060-2.61%
Close Nov 29 13:00 ET
  • 2.247
  • +0.007+0.32%
Post 16:16 ET
281.26MMarket Cap-4000P/E (TTM)

Nautilus Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-11.71%-13.11M
-14.08%-15.46M
-29.88%-16.27M
-12.89%-51.71M
-33.95%-13.9M
-22.72%-11.74M
-0.15%-13.55M
-1.53%-12.52M
-16.73%-45.81M
1.35%-10.38M
Net income from continuing operations
-3.58%-16.45M
-13.93%-18.01M
-25.16%-18.73M
-9.93%-63.68M
-26.96%-17.02M
-12.91%-15.88M
-7.62%-15.81M
5.06%-14.97M
-15.12%-57.92M
19.65%-13.41M
Depreciation and amortization
8.70%1.61M
9.31%1.6M
35.87%1.59M
67.01%5.71M
72.64%1.59M
72.44%1.48M
76.24%1.46M
45.29%1.17M
20.20%3.42M
5.98%921K
Change In working capital
-513.41%-740K
-4.11%-1.62M
-61.78%-1.49M
-308.50%-3.22M
-434.88%-920K
-81.37%179K
24.53%-1.56M
-289.51%-921K
-3,481.82%-788K
-106.51%-172K
-Change in prepaid assets
149.45%45K
186.86%238K
39.77%-309K
-208.60%-821K
-88.97%57K
-112.26%-91K
74.08%-274K
-192.60%-513K
127.49%756K
-53.42%517K
-Change in payables and accrued expense
-77.17%250K
-93.55%-840K
-247.46%-174K
632.89%810K
119.14%31K
64.91%1.1M
23.59%-434K
237.21%118K
-104.32%-152K
-114.78%-162K
-Change in other current liabilities
-25.45%-1.04M
-20.02%-1.02M
-91.44%-1.01M
-130.46%-3.21M
-91.27%-1.01M
-85.39%-825K
-93.84%-849K
-3,022.22%-526K
-76.65%-1.39M
-221.15%-527K
Cash from discontinued investing activities
Operating cash flow
-11.71%-13.11M
-14.08%-15.46M
-29.88%-16.27M
-12.89%-51.71M
-33.95%-13.9M
-22.72%-11.74M
-0.15%-13.55M
-1.53%-12.52M
-16.73%-45.81M
1.35%-10.38M
Investing cash flow
Cash flow from continuing investing activities
-157.38%-7.5M
733.88%14.29M
265.64%22.35M
-69.91%-43.74M
35.90%-41.06M
209.48%13.08M
-106.43%-2.26M
-188.89%-13.5M
81.48%-25.74M
-1,156.32%-64.06M
Net PPE purchase and sale
18.88%-709K
-10.58%-512K
6.50%-647K
-5.08%-2.44M
-80.35%-413K
9.24%-874K
28.88%-463K
-43.87%-692K
-2.42%-2.32M
76.77%-229K
Net investment purchase and sale
-148.71%-6.79M
926.23%14.81M
279.65%23M
-76.35%-41.29M
36.32%-40.65M
227.04%13.95M
-105.02%-1.79M
-181.74%-12.8M
82.87%-23.42M
-1,005.33%-63.83M
Cash from discontinued investing activities
Investing cash flow
-157.38%-7.5M
733.88%14.29M
265.64%22.35M
-69.91%-43.74M
35.90%-41.06M
209.48%13.08M
-106.43%-2.26M
-188.89%-13.5M
81.48%-25.74M
-1,156.32%-64.06M
Financing cash flow
Cash flow from continuing financing activities
775.00%140K
225.51%319K
24,400.00%245K
-34.52%368K
87.41%253K
-81.40%16K
-47.03%98K
-99.36%1K
-99.83%562K
114.29%135K
Proceeds from stock option exercised by employees
775.00%140K
225.51%319K
24,400.00%245K
-34.52%368K
87.41%253K
-81.40%16K
-47.03%98K
-99.36%1K
236.53%562K
114.29%135K
Cash from discontinued financing activities
Financing cash flow
775.00%140K
225.51%319K
24,400.00%245K
-34.52%368K
87.41%253K
-81.40%16K
-47.03%98K
-99.36%1K
-99.83%562K
114.29%135K
Net cash flow
Beginning cash position
-64.90%25.89M
-70.12%26.73M
-82.34%20.4M
-38.07%115.48M
-60.42%75.11M
-65.08%73.75M
-52.78%89.46M
-38.07%115.48M
400.98%186.46M
-0.57%189.77M
Current changes in cash
-1,613.38%-20.48M
94.63%-844K
124.34%6.33M
-33.94%-95.08M
26.37%-54.71M
106.32%1.35M
-172.27%-15.71M
-966.40%-26.02M
-147.56%-70.98M
-1,591.64%-74.3M
End cash Position
-92.80%5.41M
-64.90%25.89M
-70.12%26.73M
-82.34%20.4M
-82.34%20.4M
-60.42%75.11M
-65.08%73.75M
-52.78%89.46M
-38.07%115.48M
-38.07%115.48M
Free cash flow
-9.59%-13.82M
-13.97%-15.97M
-27.97%-16.91M
-12.51%-54.15M
-34.95%-14.31M
-19.79%-12.61M
1.18%-14.01M
-3.12%-13.22M
-15.95%-48.13M
7.81%-10.61M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -11.71%-13.11M-14.08%-15.46M-29.88%-16.27M-12.89%-51.71M-33.95%-13.9M-22.72%-11.74M-0.15%-13.55M-1.53%-12.52M-16.73%-45.81M1.35%-10.38M
Net income from continuing operations -3.58%-16.45M-13.93%-18.01M-25.16%-18.73M-9.93%-63.68M-26.96%-17.02M-12.91%-15.88M-7.62%-15.81M5.06%-14.97M-15.12%-57.92M19.65%-13.41M
Depreciation and amortization 8.70%1.61M9.31%1.6M35.87%1.59M67.01%5.71M72.64%1.59M72.44%1.48M76.24%1.46M45.29%1.17M20.20%3.42M5.98%921K
Change In working capital -513.41%-740K-4.11%-1.62M-61.78%-1.49M-308.50%-3.22M-434.88%-920K-81.37%179K24.53%-1.56M-289.51%-921K-3,481.82%-788K-106.51%-172K
-Change in prepaid assets 149.45%45K186.86%238K39.77%-309K-208.60%-821K-88.97%57K-112.26%-91K74.08%-274K-192.60%-513K127.49%756K-53.42%517K
-Change in payables and accrued expense -77.17%250K-93.55%-840K-247.46%-174K632.89%810K119.14%31K64.91%1.1M23.59%-434K237.21%118K-104.32%-152K-114.78%-162K
-Change in other current liabilities -25.45%-1.04M-20.02%-1.02M-91.44%-1.01M-130.46%-3.21M-91.27%-1.01M-85.39%-825K-93.84%-849K-3,022.22%-526K-76.65%-1.39M-221.15%-527K
Cash from discontinued investing activities
Operating cash flow -11.71%-13.11M-14.08%-15.46M-29.88%-16.27M-12.89%-51.71M-33.95%-13.9M-22.72%-11.74M-0.15%-13.55M-1.53%-12.52M-16.73%-45.81M1.35%-10.38M
Investing cash flow
Cash flow from continuing investing activities -157.38%-7.5M733.88%14.29M265.64%22.35M-69.91%-43.74M35.90%-41.06M209.48%13.08M-106.43%-2.26M-188.89%-13.5M81.48%-25.74M-1,156.32%-64.06M
Net PPE purchase and sale 18.88%-709K-10.58%-512K6.50%-647K-5.08%-2.44M-80.35%-413K9.24%-874K28.88%-463K-43.87%-692K-2.42%-2.32M76.77%-229K
Net investment purchase and sale -148.71%-6.79M926.23%14.81M279.65%23M-76.35%-41.29M36.32%-40.65M227.04%13.95M-105.02%-1.79M-181.74%-12.8M82.87%-23.42M-1,005.33%-63.83M
Cash from discontinued investing activities
Investing cash flow -157.38%-7.5M733.88%14.29M265.64%22.35M-69.91%-43.74M35.90%-41.06M209.48%13.08M-106.43%-2.26M-188.89%-13.5M81.48%-25.74M-1,156.32%-64.06M
Financing cash flow
Cash flow from continuing financing activities 775.00%140K225.51%319K24,400.00%245K-34.52%368K87.41%253K-81.40%16K-47.03%98K-99.36%1K-99.83%562K114.29%135K
Proceeds from stock option exercised by employees 775.00%140K225.51%319K24,400.00%245K-34.52%368K87.41%253K-81.40%16K-47.03%98K-99.36%1K236.53%562K114.29%135K
Cash from discontinued financing activities
Financing cash flow 775.00%140K225.51%319K24,400.00%245K-34.52%368K87.41%253K-81.40%16K-47.03%98K-99.36%1K-99.83%562K114.29%135K
Net cash flow
Beginning cash position -64.90%25.89M-70.12%26.73M-82.34%20.4M-38.07%115.48M-60.42%75.11M-65.08%73.75M-52.78%89.46M-38.07%115.48M400.98%186.46M-0.57%189.77M
Current changes in cash -1,613.38%-20.48M94.63%-844K124.34%6.33M-33.94%-95.08M26.37%-54.71M106.32%1.35M-172.27%-15.71M-966.40%-26.02M-147.56%-70.98M-1,591.64%-74.3M
End cash Position -92.80%5.41M-64.90%25.89M-70.12%26.73M-82.34%20.4M-82.34%20.4M-60.42%75.11M-65.08%73.75M-52.78%89.46M-38.07%115.48M-38.07%115.48M
Free cash flow -9.59%-13.82M-13.97%-15.97M-27.97%-16.91M-12.51%-54.15M-34.95%-14.31M-19.79%-12.61M1.18%-14.01M-3.12%-13.22M-15.95%-48.13M7.81%-10.61M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data